Are you curious about the evolving landscape of generic substitution in Southeast Asia and other emerging markets? Our latest white paper, Generic Substitution in Southeast Asia and Emerging Markets: Key Insights for Strategic Decision-Making, delves into the intricate dynamics shaping this critical aspect of the pharmaceutical industry. Authored by industry experts Robin Arnold, Ankit Kulshrestha and Abheek Bose, this comprehensive analysis explores the factors influencing substitution behavior, from price sensitivity and therapeutic category variations to the pivotal role of prescriber endorsements and geographic differences. Discover how these insights can inform your strategic planning and resource allocation decisions, helping you navigate these rapidly changing markets with confidence.
In this white paper, we present a series of exploratory hypotheses designed to provide a framework for pharmaceutical companies to develop market-specific strategies. Learn about the threshold-based relationship between price differentials and substitution behavior, the importance of category-specific analysis, and the significant impact of health literacy on generic acceptance. With detailed evidence and strategic considerations, this paper offers valuable guidance for companies looking to optimize their approach in Southeast Asia and other emerging markets. Don’t miss out on these key insights that could transform your understanding of generic substitution and drive your business forward.
Complete the form below to download the full paper.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…